Xilio Therapeutics, Inc.
XLOCIK 0001840233 · Every Form 4 filed by insiders at this issuer.
Filings
3
Latest Feb 9, 2024
Unique insiders
7
Showing
3 of 3
Page 1
Top insiders
Most active reporters at Xilio Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Atlas Venture Associates Opportunity I, L.P. | 10% Owner | 2 |
| Atlas Venture Associates Opportunity I, LLC | 10% Owner | 2 |
| Atlas Venture Associates XI, L.P. | 10% Owner | 2 |
| Atlas Venture Associates XI, LLC | 10% Owner | 2 |
| Atlas Venture Fund XI, L.P. | 10% Owner | 2 |
| Atlas Venture Opportunity Fund I, L.P. | 10% Owner | 2 |
| Russo Rene | OfficerDirector | 1 |
All filings
3 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 9, 2024 | Atlas Venture Fund XI, L.P. 10% Owner | S | 733 | $0.64 | $469 | |
| Jan 16, 2024 | Atlas Venture Fund XI, L.P. 10% Owner | S | 1,566 | $0.87 | $1,362 | |
| Jan 3, 2024 | Russo Rene PRESIDENT AND CEO · Director | Holdings only | — | — | — |
Showing 1–3 of 3
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.